SCHEMBL10735009

SCHEMBL10735009

C#CCOc1ccc(-c2nc3cnncc3[nH]2)c(OCC=C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 1/20 0.37
▸ TOP2A P11388 1/20 0.37
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ LMNA P02545 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ PARP1 P09874 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ PDE2A O00408 1/20 0.32
▸ MAOA P21397 8/20 0.32
▸ MAOB P27338 8/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ PDE5A O76074 1/20 0.31
▸ PDE3B Q13370 1/20 0.31
▸ PDE3A Q14432 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10735022 0.96 LMNA (0.35) TOP1TOP2ACYP1A1CYP1A2CYP1B1
SCHEMBL10739175 0.90 TOP1 (0.41) TOP1TOP2ACYP1A1CYP1A2CYP1B1
SCHEMBL10739674 0.90 LMNA (0.39) LMNASMN1; SMN2NPSR1PARP1FGFR1
SCHEMBL10737718 0.90 LMNA (0.35) LMNASMN1; SMN2NPSR1FGFR1PDE2A
SCHEMBL9634601 0.88 TOP1 (0.36) TOP1TOP2ACYP1A1CYP1A2CYP1B1
SCHEMBL10736446 0.86 TOP1 (0.41) TOP1TOP2ACYP1A1CYP1A2CYP1B1
SCHEMBL10743319 0.86 LMNA (0.37) LMNASMN1; SMN2NPSR1FGFR1PDE2A
SCHEMBL10735482 0.85 TOP1 (0.38) TOP1TOP2ACYP1A1CYP1A2CYP1B1
SCHEMBL10739803 0.85 TOP1 (0.38) TOP1TOP2ACYP1A1CYP1A2CYP1B1
SCHEMBL10733841 0.85 PDE2A (0.46) TOP1TOP2ACYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback